Journal profile · Medicine
Current Atherosclerosis Reports
ISSN 1523-3804 · eISSN 1534-6242 · Springer US · US · Bimonthly · Founded 1999
Current Atherosclerosis Reports: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6.63; hybrid open access; APC about USD 5,190; median 72 days to acceptance (38 articles, last 24 months); community-reported acceptance: fairly easy; 107 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Atherosclerosis Reports is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Atherosclerosis and Cardiovascular Diseases, together about 35.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The aim of this journal is to systematically provide expert views on current basic science and clinical advances in the field of atherosclerosis and highlight the most important developments likely to transform the field of cardiovascular prevention, diagnosis, and treatment. We accomplish this aim by appointing major authorities to serve as Section Editors who select leading experts from around the world to provide definitive reviews on key topics and papers published in the past year. We also provide supplementary reviews and commentaries from well-known figures in the field. An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.
From the journal's Aims & Scope
Editor-in-chief Antonio M. GottoPublisher website
Editorial board by country: none in mainland China; most named United States 24, Brazil 6, Pakistan 4, Canada 2, Australia 2 (46 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lipoproteins and Cardiovascular HealthMedicine19.2%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine10.7%
- Atherosclerosis and Cardiovascular DiseasesImmunology and Microbiology5.9%
- Cancer, Lipids, and MetabolismBiochemistry, Genetics and Molecular Biology5%
- Cardiac Imaging and DiagnosticsMedicine4.7%
- Coronary Interventions and DiagnosticsMedicine4.2%
- Diet and metabolism studiesMedicine4.1%
- Cerebrovascular and Carotid Artery DiseasesMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.63LetPub ·
- Impact factor (publisher) 2025
- 6.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 6.7Publisher website ·
- CiteScore 2026-06
- 10.5LetPub ·
- SJR 2026-06
- 1.95LetPub ·
- SNIP 2026-06
- 1.63LetPub ·
- h-index
- 66LetPub ·
- h-index
- 113OpenAlex ·
- i10-index
- 1,371OpenAlex ·
- 2-year mean citedness
- 7.3OpenAlex ·
- Self-citation rate
- 1.5%LetPub ·
- Share of gold OA articles
- 30.69%LetPub ·
Volume
- Articles per year
- 100LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 764,800Publisher website ·
Articles by year OpenAlex count · 2,236 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 91 | 44 | 92 |
| 2025 | 107 | 45 | 739 |
| 2024 | 80 | 28 | 1,199 |
| 2023 | 107 | 49 | 2,120 |
| 2022 | 97 | 49 | 2,680 |
| 2021 | 80 | 48 | 3,197 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
72 daysMedian, submission to acceptance · P25–P75 48 days – 139 days
- Acceptance to online
- median 19 days (94 articles)
- Submission to online
- median 113 days
- Sample
- 38 articles with submission and acceptance dates (131 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 15 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,190 / EUR 4,190 / GBP 3,490 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted4
- commentaryReviews and Invited Commentaries Back to topLength not stated
- invited commentariesTypes of papers Reviews and Invited CommentariesLength not stated
- reviewReviews and Invited Commentaries Back to topLength not stated
- reviewsTypes of papers Reviews and Invited CommentariesLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
Competing interests disclosure required Model summary
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
Data transparency policy Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Permissions required for previously published material Model summary
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Current Atherosclerosis Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- US
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1999
- ISSN
- 1523-3804
- Electronic ISSN
- 1534-6242
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Atherosclerosis Reports
What CAS zone is Current Atherosclerosis Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Atherosclerosis Reports is in Zone 2 of Medicine, and in Zone 2 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Atherosclerosis Reports?
The latest impact factor listed by LetPub is 6.63; CiteScore 10.5, h-index 113.
How long does peer review take at Current Atherosclerosis Reports?
Based on the dates recorded on 38 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 48–139 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Atherosclerosis Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Atherosclerosis Reports based?
Of the 46 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (24), Brazil (6) and Pakistan (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Atherosclerosis Reports?
According to LetPub and DOAJ records, Current Atherosclerosis Reports is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Current Atherosclerosis Reports open access, and what is the APC?
Current Atherosclerosis Reports is a hybrid journal. For open-access publication: APC about USD 5,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .